G1-4A, an immunomodulatory polysaccharide from Tinospora cordifolia, modulates macrophage responses and protects mice against lipopolysaccharide induced endotoxic shock

International Immunopharmacology

Volumn 7, Issue 10, 2007, Pages 1375-1386

  Desai, Veena R ^a   Ramkrishnan, Rupal ^a   Chintalwar, Gajanan J ^a   Sainis, K B ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Cytokines; Endotoxic shock; Lipopolysaccharide; Nitric oxide; Tinospora cordifolia; TNF

Indexed keywords

ARABINOGALACTAN; CYTOKINE; ENDOTOXIN; G1 4A; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; POLYSACCHARIDE; TINOSPORA CORDIFOLIA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT RESPONSE;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; FEMALE; GALACTANS; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MACROPHAGES; MALE; MEDICINE, AYURVEDIC; MICE; MICE, INBRED C3H; NITRIC OXIDE; PLANT EXTRACTS; PLANTS, MEDICINAL; RNA, MESSENGER; SHOCK, SEPTIC; SPLEEN; TINOSPORA; U937 CELLS;

EID: 34547220432     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.06.004     Document Type: Article

References (45)

1. Schepetkin I.A., and Quinn M.T. Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6 (2006) 317-333
2. Beutler B. Innate immunity: an overview. Mol Immunol 40 (2004) 845-859
3. Thatte U.M., Chhabria S., Karandikar S.M., and Dahanukar S.A. Immunotherapeutic modification of Escherichia coli abdominal sepsis and mortality in mice by Indian medicinal plants. Ind Drugs 25 (1987) 95-98
4. Thatte U.M., and Dahanukar S.A. Immunotherapeutic modification of experimental infections by Indian medicinal plants. Phytother Res 3 (1989) 43-49
5. Sainis K.B., Sumariwalla P.F., Goel A., Chintalwar G.J., Sipahimalani A.T., and Banerji A. Immunomodulatory properties of stem extracts of Tinospora cordifolia: Cell targets and active principles. In: Upadhyay S.N. (Ed). Immunomodulation (1997), Narosa Publishing House, New Delhi 155-162
6. Chintalwar G., Jain A., Sipahimalani A., Banerji A., Sumariwalla P., Ramakrishnan R., et al. An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry 52 (1999) 1089-1093
7. Sainis K.B., Ramakrishnan R., Sumariwalla P.F., Sipahimalani A., Chintalwar G.J., and Banerji A. Further studies on immunomodulation by natural products from Tinospora cordifolia. In: Upadhyay S.N. (Ed). Imuunopharmacology (1999), Narosa Publishing House, New Delhi 96-104
8. Nair P.K., Rodriguez S., Ramachandran R., Alamo A., Melnick S.J., Escalon E., et al. Immune stimulating properties of a novel polysaccharide from medicinal plant Tinospora cordifolia. Int Immunopharmacol 4 (2004) 1645-1659
9. Netea M.G., Kullberg B.J., Joosten L.A., Sprong T., Verschueren I., Boerman O.C., et al. Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur J Immunol 31 (2001) 2529-2538
10. Das U.N. Critical advances in septicemia and septic shock. Crit Care 4 (2000) 290-296
11. Kakutani M.K., Waga T.I., Iwamura H., and Wakitani K. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression protects from endotoxin shock in mice. Inflamm Res 48 (1999) 461-468
12. Krakauer T., and Stiles B.G. Pentoxyfiline inhibits superantigen-induced toxic shock and cytokine release. Clin Diagn Lab Immunol 6 (1999) 594-598
13. Howe L.M. Novel agents in the therapy of endotoxic shock. Expert Opin Investig Drugs 9 (2000) 1363-1372
14. Moreira A.L., Wang J., Sarno E.N., and Kaplan G. Thalidomide protects mice against LPS-induced shock. Braz J Med Biol Res 30 (1997) 1199-1207
15. Davenpeck K.L., Zagorski J., Schleimer R.P., and Bochner B.S. Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J Immunol 161 (1988) 6861-6870
16. Tollner B., Roth J., Storr B., Martin D., Voigt K., and Zeisberger E. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide. Eur J Physiol 440 (2000) 925-932
17. Roberts F.A., Richardson G.J., and Michalek S.M. Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun 65 (1997) 3248-3254
18. Luk J.M., Kumar A., Tsang R., and Staunton D. Biotinylated lipopolysaccharide binds to endotoxin receptor in endothelial and monocytic cells. Anal Biochem 232 (1995) 217-224
19. Wysocki L.J., and Sato V.L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A 75 (1978) 2844-2848
20. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141 (1988) 2407-2412
21. Sladowski D., Steer S.J., Clothier R.H., and Balls R.H. An improved MTT assay. J Immunol Methods 157 (1993) 203-207
22. Ohtani K., Okai K., Yamashita U., Yuasa I., and Misaki A. Characterization of an acidic polysaccharide isolated from the leaves of Corchorus olitorius (Moroheiya). Biosci Biotechnol Biochem 59 (1995) 378-381
23. Haas J.G., Baeuerle P.A., Riethmuller G., and Ziegler-Heitbrock H.W.L. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci U S A 87 (1990) 9563-9567
24. Beutler B., Milsark I.W., and Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229 (1985) 869-871
25. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330 (1987) 662-664
26. Alexander H.R., Doherty G.M., Block M.I., Kragel P.J., Jensen J.C., Langstein H.N., et al. Single dose tumor necrosis factor protection against endotoxin induced shock and tissue injury in rats. Infect Immun 59 (1991) 3889-3894
27. Alves-Rosa F., Vulcano M., Beigier-Bompadre M., Fernandez G., Palermo M., and Isturiz M.A. Interleukin-1β induces in vivo tolerance to lipopolysaccharide in mice. Clin Exp Immunol 128 (2002) 221-228
28. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface toll-like receptor 4 expression. J Immunol 164 (2000) 3476-3479
29. Di Santo E., Alonzi T., Poli V., Fattori E., Toniatti C., Sironi M., et al. Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine 9 (1997) 300-306
30. Doherty G.M., Lange J.R., Langstein H.N., Alexander H.R., Buresh C.M., and Norton J.A. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 149 (1992) 1666-1670
31. Sanchez-Cantu L., Rode H.N., Yun T.J., and Christou N.V. Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg 126 (1991) 231-235
32. Docke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3 (1997) 678-681
33. Opal S.M., and DePal P.A. Anti-inflammatory cytokines. Chest 117 (2000) 1162-1172
34. Gogos C.A., Drosou E., Bassaris H.P., and Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181 (2000) 176-180
35. Janssen-Heininger Y.M.W., Poynter M.E., and Baeuerle P.A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappa B. Free Radic Biol Med 28 (2000) 1317-1327
36. Zingarelli B., Halushka P.V., Caputi P.V., and Cook J.A. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 3 (1995) 102-108
37. Desai V.R., Kamat J.P., and Sainis K.B. An immunomodulator from Tinospora cordifolia with antioxidant activity in cell-free systems. Proc Indian Acad Sci (Chem Sci) 114 (2002) 713-719
38. Subramanian M., Chintalwar G.J., and Chattopadhyay S. Antioxidant properties of a Tinospora cordifolia polysaccharide against iron-mediated lipid damage and gamma-ray induced protein damage. Redox Rep 7 (2002) 137-143
39. Subramanian M., Chintalwar G.J., and Chattopadhyay S. Radioprotective property of polysaccharide in Tinospora cordifolia. Indian J Biochem Biophys 40 (2003) 22-26
40. Cadenas S., and Cadenas A. Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology 180 (2002) 45-63
41. Victor V.M., Rocha M., and De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4 (2004) 327-347
42. Nelson S. A question of balance. Am J Respir Crit Care Med 159 (1999) 1365-1367
43. Oberholzer A., Oberholzer C., and Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16 (2001) 83-96
44. Bapat R.D., Rege N.N., Koti R.S., Desai N.K., and Dahanukar S.A. Can we do away with PTBD?. HPB Surg 9 (1995) 5-11
45. Rege N.N., Bapat R.D., Koti R., Desai N.K., and Dahanukar S. Immunotherapy with Tinospora cordifolia: a new lead in management of obstructive jaundice. Indian J Gastroenterol 12 (1993) 5-8